Opvee (nalmefene), is an intranasal opioid antagonist used for opioid overdose and was approved by the FDA in 2023. This approval provided another tool to aid in combating the opioid crisis. There are currently two medications, Opvee and Narcan (naloxone), that can...
In this blog post, I want to share some important SSRI clinical pearls that help clinicians decide which of these antidepressants to use. Note that these clinical practice pearls are good examples of some testable items that may show up on your board exam 🙂 Sertraline...
Rivaroxaban is classified as a direct oral anticoagulant. It is one of the most commonly used anticoagulants within this class (in addition to apixaban). In this blog post, I’ll share the 5 most important rivaroxaban clinical pearls that may appear in practice...
Bactrim (sulfamethoxazole/trimethoprim) is a commonly used antibiotic associated with many adverse events that include neutropenia, thrombocytopenia, rash, hepatitis, and electrolyte abnormalities. Bactrim also has the potential to elevate serum creatinine but it may...
The American Academy of Dermatology released guidelines for the treatment of acne in early 2024. As I’m updating study materials, I thought I’d share a sneak peek of my top 5 takeaways from the 2024 Acne Guidelines. Retinoids and Benzoyl Peroxide In mild...
Benazepril and lisinopril are both ACE Inhibitors that are commonly used in practice. Lisinopril is the most frequently used ACE inhibitor. In this article, we will compare benazepril versus lisinopril and highlight some of the differences that may help guide the...
